Nor0f 0007 01
Norepinephrine Bitartrate Solution
Product Images NDC 63323-940
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Norepinephrine Bitartrate (NDC 63323-940). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Nor0f 0007 02
Nor0f 0007 03
Norepinephrine Bitartrate Injection, USP is a potent drug available in single-dose vials with a concentration of 4 mg per 4 mL (1 mg per mL). It is meant for intravenous infusion only and should be controlled by frequent determination of blood pressure. The package warning contains Sulfites, and the medication needs to be diluted before use. It is crucial to protect the drug from light, avoid extravasation, and read the package insert carefully. The medication comes in packs of 10x 4 mL single-dose vials, and unused portions should be discarded. It is manufactured by Fresenius Kabi.*
Nor0f 0007 04
Norepinephrine Bitartrate Injection, USP is a medication meant for intravenous infusion only. It contains 4 mg of norepinephrine bitartrate per 4 mL (1 mg per mL) and is available in a 4 mL single-dose vial. The medication should be used with caution as it contains sulfites. The unused portion should be discarded and it can be obtained only via a prescription (Rx Only).*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
